Psychiatry and Neurology, Neurology · Naples, FL
NPI
1154372167
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
3200 Bailey Ln Ste 200
Naples, FL, 34105
Phone (239) 262-8971
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.4M
67,711 services
Medicare patients, 2024
609
Average age 74
Drug cost, 2024
$4.8M
4,710 prescriptions
Company payments, 2025
$288K
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew J Baker was code J2350 (injection, ocrelizumab, 1 mg), 25,200 times for 26 patients. In total Matthew J Baker billed 67,711 services in 44 codes, and Medicare paid $3.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2350 Injection, ocrelizumab, 1 mg | Office | 25,200 | 26 | $46.66 | $1.2M |
| 99215 Office E&M - Established | Office | 766 | 446 | $134.92 | $103K |
| 99214 Office E&M - Established | Office | 385 | 253 | $90.27 | $35K |
| 99232 Hospital E&M - Subsequent | Facility | 381 | 43 | $63.30 | $24K |
| 96413 Chemotherapy Administration | Office | 150 | 44 | $97.68 | $15K |
| 96415 Chemotherapy Administration | Office | 66 | 32 | $21.09 | $1,392 |
| 70553 MRI/MRA - Head and Neck | Office | 46 | 46 | $85.27 | $3,922 |
| 99222 Hospital E&M - Initial | Facility | 34 | 27 | $105.57 | $3,589 |
| 96375 Injection Administration | Office | 30 | 21 | $12.16 | $365 |
| 99233 Hospital E&M - Subsequent | Facility | 29 | 13 | $95.43 | $2,767 |
| 99205 Office E&M - New | Office | 18 | 18 | $172.94 | $3,113 |
| 99223 Hospital E&M - Initial | Facility | 17 | 16 | $130.44 | $2,217 |
By year: 2022 $2.7M for 46,172 services; 2023 $2.9M for 48,875 services; 2024 $3.4M for 67,711 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew J Baker prescribed most often to Medicare patients was Gabapentin, with 336 prescriptions and refills. In total Matthew J Baker wrote 4,710 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 336 | 730 | 99 | $10K |
| Baclofen Generic | 212 | 509 | 64 | $8,052 |
| Dalfampridine Er Dalfampridine | 205 | 299 | 34 | $136K |
| Duloxetine Hcl Generic | 131 | 283 | 29 | $3,032 |
| Pregabalin Generic | 128 | 212 | 30 | $4,718 |
| Diazepam Generic | 121 | 155 | 31 | $1,479 |
| Alprazolam Generic | 119 | 136 | 30 | $848 |
| Levetiracetam Generic | 111 | 278 | 27 | $5,276 |
| Clonazepam Generic | 108 | 144 | 21 | $952 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 96 | 248 | 34 | $2,185 |
| Copaxone Glatiramer Acetate | 87 | 92 | Under 11 | $505K |
| Donepezil Hcl Generic | 82 | 166 | 19 | $975 |
| Memantine Hcl Generic | 77 | 154 | 21 | $2,445 |
| Methylprednisolone Generic | 72 | 86 | 33 | $1,452 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 64 | 153 | 16 | $1,453 |
Brand drugs: - claims; generic drugs: 3,769 claims; opioid claims: 134.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew J Baker $288K ($288K in general payments such as food, travel and fees) from 35 companies. The largest payer was EMD Serono, Inc. with $82K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 67 | $82K |
| TG Therapeutics, Inc. TGTX | 38 | $44K |
| Alexion Pharmaceuticals, Inc. AZN | 38 | $41K |
| E.R. Squibb & Sons, L.L.C. BMY | 27 | $39K |
| Biogen, Inc. BIIB | 32 | $38K |
| Mallinckrodt Hospital Products Inc. | 15 | $18K |
| Abbvie Inc. ABBV | 40 | $12K |
| Genentech USA, Inc. ROG.SW | 11 | $8,018 |
| Ares Trading SA | 1 | $3,128 |
| Argenx US, Inc. ARGX | 7 | $488 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.